Michael Kassiou

14.0k citations

309 papers · 10.3k indexed · 2 hit papers · h-index 54

Impact in

Biological Psychiatry top 0.5%
Toxicology top 0.05%
- Forensic Toxicology and Drug Analysis

Papers in

Physiology 34
- Adenosine and Purinergic Signaling 34
- Alzheimer's disease research and treatments 27
Cellular and Molecular Neuroscience 85
- Neuroscience and Neuropharmacology Research 53

Co-authors: Louis M. Rendina Samuel D. Banister Fatiah Issa Tristan A. Reekie Steven R. Meikle Jonathan J. Danon Iain S. McGregor Richard B. Banati
Journals: Bioorganic & Medicinal Chemistry Letters (21 papers)ACS Chemical Neuroscience (17 papers)Australian Journal of Chemistry (14 papers)European Journal of Medicinal Chemistry (12 papers)Nuclear Medicine and Biology (12 papers)
Partner nations: Australia United States France

In The Last Decade

Michael Kassiou

307 papers receiving 10.2k citations

Hit Papers

align trajectories log scale

Late-stage Functionalization for Improving Drug-like Molecular Properties 2023 · 135 citations

Peers

Countries citing papers authored by Michael Kassiou

Since Specialization

Citations

This map shows the geographic impact of Michael Kassiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kassiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kassiou more than expected).

Fields of papers citing papers by Michael Kassiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kassiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kassiou. The network helps show where Michael Kassiou may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Kassiou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Kassiou Line = papers co-authored together Michael Kassiou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and evaluation of [11C]DPA-813 and [18F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971 European Journal of Nuclear Medicine and Molecular Imaging ·Wissam Beaino, Esther Kooijman, Eryn L. Werry, Rens J. Vellinga, Johan van den Hoek, Greta Sohler, Grace A. Cumbers, Elijah Genetzakis, Edward D. Harvey-Latham, Robert C. Schuit, Michael Kassiou, Albert D. Windhorst, Jonathan J. Danon	2025	1
2	Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis Seminars in Nuclear Medicine ·Grace A. Cumbers, Edward D. Harvey-Latham, Michael Kassiou, Eryn L. Werry, Jonathan J. Danon	2024	9
3	Three‐dimensional bioprinting of stem cell‐derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/function Biotechnology and Bioengineering ·Michael A. Sullivan, Samuel Lane, Alexander Volkerling, Martin Engel, Eryn L. Werry, Michael Kassiou	2023	14
4	High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix® Technology International Journal of Molecular Sciences ·Weiqian Eugene Lee, Marie Besnier, Elijah Genetzakis, Owen Tang, Katharine A. Kott, Stephen T. Vernon, Michael P. Gray, Stuart M. Grieve, Michael Kassiou, Gemma A. Figtree	2023	4
5	Quantification of the purinergic P2X₇ receptor with [¹¹C]SMW139 improves through correction for brain-penetrating radiometabolites Journal of Cerebral Blood Flow & Metabolism ·Joachim Brumberg, Richard Aarnio, Anton Forsberg, Päivi Marjamäki, Vera S. Kerstens, Mohammad Mahdi Moein, Sangram Nag, Saara Wahlroos, Michael Kassiou, Albert D. Windhorst, Christer Halldin, Merja Haaparanta‐Solin, Patrik Fazio, Vesa Oikonen, Juha O. Rinne, Andrea Varrone	2022	4
6	Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis Brain ·Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday, Woojin S. Kim	2022	31
7	Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line European Journal of Pharmacology ·Zara Sheikh, Peta Bradbury, Tristan A. Reekie, Michele Pozzoli, Paul D. Robinson, Michael Kassiou, Paul M. Young, Hui Xin Ong, Daniela Traini	2021	2
8	Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells RSC Medicinal Chemistry ·Shahinda S. R. Alsayed, Amreena Suri, Anders W. Bailey, Samuel Lane, Eryn L. Werry, Chiang‐Ching Huang, Li-Fang Yu, Michael Kassiou, Simone Treiger Sredni, Hendra Gunosewoyo	2021	4
9	Cannabis and Cannabinoids Australian Journal of Chemistry ·Peter J. Duggan, Michael Kassiou	2021	1
10	In vitro determination of the efficacy of illicit synthetic cannabinoids at CB ₁ receptors British Journal of Pharmacology ·Shivani Sachdev, Kiran Vemuri, Samuel D. Banister, Mitchell Longworth, Michael Kassiou, Marina Santiago, Alexandros Makriyannis, Mark Connor	2019	39
11	Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids European Journal of Medicinal Chemistry ·Michael Moir, Samuel Lane, Felcia Lai, Mark Connor, David E. Hibbs, Michael Kassiou	2019	23
12	Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases Journal of Medicinal Chemistry ·Natalie B. Vinh, Nyssa Drinkwater, Tess R. Malcolm, Michael Kassiou, Leonardo Lucantoni, Peter M. Grin, Georgina S. Butler, Sandra Duffy, Christopher M. Overall, Vicky M. Avery, Peter J. Scammells, Sheena McGowan	2018	27
13	N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as σ receptor ligands with potential neuroprotective effects Bioorganic & Medicinal Chemistry ·Samuel D. Banister, Miral Manoli, Melissa L. Barron, Eryn L. Werry, Michael Kassiou	2013	17
14	The translocator protein (TSPO): A novel target for cancer chemotherapy The International Journal of Biochemistry & Cell Biology ·Christopher Austin, Jan Kahlert, Michael Kassiou, Louis M. Rendina	2013	81
15	The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor‐Binding Profile, Prosocial Effects and Distribution of c‐Fos Expression in Adolescent Rats Journal of Neuroendocrinology ·Callum Hicks, William T. Jorgensen, Christopher Brown, Joanna E. Fardell, Johannes Koehbach, Christian W. Gruber, Michael Kassiou, Glenn E. Hunt, Iain S. McGregor	2012	64
16	Initial Evaluation of ¹¹C-DPA-713, a Novel TSPO PET Ligand, in Humans Journal of Nuclear Medicine ·Christopher J. Endres, Martin G. Pomper, Michelle L. James, Övsev Uzuner, Dima A. Hammoud, Crystal C. Watkins, Aaron Reynolds, John Hilton, Robert F. Dannals, Michael Kassiou	2009	114
17	Comparative Evaluation of the Translocator Protein Radioligands ¹¹C-DPA-713, ¹⁸F-DPA-714, and ¹¹C-PK11195 in a Rat Model of Acute Neuroinflammation Journal of Nuclear Medicine ·Fabien Chauveau, Nadja Van Camp, Frédéric Dollé, Bertrand Kühnast, Françoise Hinnen, Annelaure Damont, Hervé Boutin, Michelle L. James, Michael Kassiou, Bertrand Tavitian	2009	194
18	Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning Neuroscience Letters ·Mitchell Quinlivan, Sylvie Chalon, Jackie Vergote, J. M. Henderson, Andrew Katsifis, Michael Kassiou, Denis Guilloteau	2007	9
19	Acetylenic Pyridines for Use in PET Imaging of Nicotinic Receptors ChemMedChem ·Alan P. Kozikowski, Sheela K. Chellappan, David Henderson, Roger Fulton, Nicolas Giboureau, Yingxian Xiao, Zhi‐Liang Wei, Denis Guilloteau, Patrick Emond, Frédéric Dollé, Kenneth J. Kellar, Michael Kassiou	2006	9
20	In vitro and in vivo characterisation of [3H]ANSTO-14 binding to the σ1 binding sites Nuclear Medicine and Biology ·Vu Nguyen, Karine Mardon, Michael Kassiou, MacDonald J. Christie	1999	5

About Michael Kassiou

Michael Kassiou is a scholar working on Physiology, Cellular and Molecular Neuroscience, Neurology, Toxicology and Biological Psychiatry, having authored 309 papers that have together received 10.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (54 papers), Neuroscience and Neuropharmacology Research (53 papers), Pharmacological Receptor Mechanisms and Effects (51 papers), Neuroinflammation and Neurodegeneration Mechanisms (35 papers), Adenosine and Purinergic Signaling (34 papers), Radiopharmaceutical Chemistry and Applications (32 papers), Nicotinic Acetylcholine Receptors Study (28 papers) and Alzheimer's disease research and treatments (27 papers). The work is most often cited by research in Biological Psychiatry (678 citations), Toxicology (851 citations), Neurology (1.6k citations), Physiology (537 citations) and Cellular and Molecular Neuroscience (2.1k citations). Michael Kassiou has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Louis M. Rendina, Samuel D. Banister, Fatiah Issa, Tristan A. Reekie, Steven R. Meikle, Jonathan J. Danon, Iain S. McGregor, Richard B. Banati, Michelle L. James and Frédéric Dollé. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Chemical Neuroscience, Australian Journal of Chemistry, European Journal of Medicinal Chemistry and Nuclear Medicine and Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact